Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: Relationship to severity of dementia and apolipoprotein E genotype

Neurology

Volumn 50, Issue 1, 1998, Pages 164-168

  Craft, Suzanne ^a,d,e   Peskind, Elaine ^a,b,d   Schwartz, Michael W ^c,d   Schellenberg, Gerard D ^a,d   Raskind, Murray ^b,d   Porte Jr , Daniel ^c,d  

^a Education   (United States)

^b Mental Health Service   (United States)

^c VA Puget Sound Health Care System ^*  (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; INSULIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN METABOLISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0031907459     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.1.164     Document Type: Article

References (26)

1. Adamo M, Raizada, MK, LeRoith D. Insulin and insulin-like growth factor receptors in the nervous system. Mol Neurobiol 1989;3:71-100.
2. Unger J, McNeill TH, Moxley RT III, White M, Moss A, Livingston JN. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 1989;31:143-157.
3. Zahniser NR, Goens MB, Hanaway PJ, Vinych JV. Characterization and regulation of insulin receptors in rat brain. J Neurochem 1984;42:1354-1362.
4. Marks JL, King MG, Baskin DG. Localization of insulin and type 1 IGF receptors in rat brain by in vitro autoradiography and in situ hybridization. Adv Exp Med Biol 1991;293:459-470.
5. Craft S, Newcomer J, Kanne S, et al. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol Aging 1996;17:123-130.
6. Craft S, Asthana S, Newcomer J, et al. Insulin-induced enhancement of memory in Alzheimer's disease is independent of glucose [abstract]. Soc Neurosci Abstr 1996;22:1177.
7. Park CR, Seeley RJ, Woods SC. ICV insulin increases performance on a passive avoidance task [abstract]. Soc Neurosci Abstr 1995;21:949.
8. Messier C, Destrade C. Insulin attentuates scopolamine-induced memory deficits. Psychobiology 1994;22:16-21.
9. Craft S, Dagogo-Jack SE, Wiethop BV, et al. The effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Beh Neurosci 1993; 107:926-940.
10. Meneilly GS, Hill A. Alterations in glucose metabolism in patients with Alzheimer's disease. J Am Geriatr Soc 1993;41: 710-714.
11. Frolich L, Blum-Degen D, Hoyer S, Riederer P. Regional distribution of insulin, insulin receptors and IGF-I receptors in post-mortem brain cortex in aging and in dementia of Alzheimer type [abstract]. Neurobiol Aging 1996;17:s184.
12. Kamboh MI. Apolipoprotein K polymorphism and susceptibility to Alzheimer's disease. Hum Biol 1995;67:195-215.
13. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
14. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
15. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, Fujimoto WY. Relationship of proinsulin and insulin with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese-American men: impact of obesity. J Clin Endocrinol Metab 1995;80:1399-1406.
16. Baura GD, Foster DM, Porte D Jr, et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest 1993;92:1824-1830.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
18. Emi M, Wu LL, Robertson MA, et al. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988; 3:373-379.
19. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
20. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 1992;13:387-414.
21. Jeanrenaud B. Central nervous system and peripheral abnormalities: clues to the understanding of obesity and NIDDM. Diabetologia 1994;37(suppl 2):s170-s178.
22. 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neural 1995;38:643-648.
23. Squire LR. Memory and the hippocampus: a synthesis of findings with rats, monkeys, and humans. Psychol Rev 1992;99: 195-231.
24. Leloup C, Arluison M, Kassis N, et al. Discrete brain areas express the insulin-responsive glucose transporter GLUT4. Brain Res Mol Brain Res 1996;38:45-53.
25. Simpson IA, Li K, Koehler-Stec EM, Gibbs EM, Vannucci J. Regional expression of the GLUT4 glucose transporter in mouse brain [abstract]. Soc Neurosci Abstr 1996;22:1571.
26. Wallace WC, Akar CA, Kole HK, Egan, JM, Wolozin B. Amyloid precursor protein potentiates the neurotrophic activity of NGF through the insulin signaling pathway [abstract]. Soc Neurosci Abstr 1996;22:513.